|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 5, 2005
Neuroproteomics, Max-Delbrück-Centrum für Molekulare Medizin, Berlin D-13125
Corresponding Author: ewanker{at}mdc-berlin.de
Proteins mediate their biological function through interactions with other proteins. Therefore, the systematic identification and characterization of protein-protein interactions has become a powerful proteomics strategy to understand protein function and comprehensive cellular regulatory networks. For the screening of VCP, CHIP and amphiphysin II interaction partners, we utilized a membrane-based array technology that allows the identification of human protein-protein interactions with crude bacterial cell extracts. Many novel interaction pairs such as VCP/AMFR, CHIP/caytaxin, or amphiphysin II/DLP4 were identified, and subsequently confirmed by pull-down, two-hybrid and co-immunoprecipitation experiments. In addition, assays were performed to validate the interactions functionally. CHIP, e.g. was found to efficiently polyubiquitinate caytaxin in vitro, suggesting that it might influence caytaxin degradation in vivo. Using peptide arrays, we also identified the binding motifs in the proteins DLP4, XRCC4 and FBP, which are crucial for the association with the SH3 domain of amphiphysin II. Together, these studies indicate that our human proteome array technology permits the identification of protein-protein interactions, which are functionally involved in neurodegenerative disease processes, the degradation of protein substrates and the transport of membrane vesicles.
Revised on November 4, 2005
Accepted on November 6, 2005
Identification of VCP/p97, CHIP and amphiphysin II interaction partners using membrane-based human proteome arrays
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Adachi, M. Waza, K. Tokui, M. Katsuno, M. Minamiyama, F. Tanaka, M. Doyu, and G. Sobue CHIP Overexpression Reduces Mutant Androgen Receptor Protein and Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model J. Neurosci., May 9, 2007; 27(19): 5115 - 5126. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Scheich, D. Kummel, D. Soumailakakis, U. Heinemann, and K. Bussow Vectors for co-expression of an unrestricted number of proteins Nucleic Acids Res., March 19, 2007; 35(6): e43 - e43. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Dickey, M. Yue, W.-L. Lin, D. W. Dickson, J. H. Dunmore, W. C. Lee, C. Zehr, G. West, S. Cao, A. M. K. Clark, et al. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species. J. Neurosci., June 28, 2006; 26(26): 6985 - 6996. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, G. Zhao, X. Zhou, H. Schindelin, and W. J. Lennarz The AAA ATPase p97 links peptide N-glycanase to the endoplasmic reticulum-associated E3 ligase autocrine motility factor receptor PNAS, May 30, 2006; 103(22): 8348 - 8353. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |